Restructurings	9 Months Ended
Restructurings	Sep. 30, 2025
Restructuring and Related Activities [Abstract]
Restructurings	Restructurings On August 20, 2024, the Company announced a reduction in force plan (the “2024 Plan”) as part of its broader efforts to drive balanced, profitable growth, further supporting its positive, long-term outlook and focus on increasing stockholder value. The 2024 Plan reduced the Company’s global full-time employees by approximately 6%. For the year ended December 31, 2024, the Company incurred a total of $9.6 million in restructuring costs under the 2024 Plan, primarily consisting of notice period payments, severance payments, employee benefits and related costs, all of which are cash expenditures, of which $2.1 million was recorded in cost of revenue, $1.9 million was recorded in research and development expenses, $4.4 million was recorded in sales and marketing expenses, and $1.2 million was recorded in general and administrative expenses on the consolidated statements of operations and comprehensive income (loss). As of September 30, 2025, $9.4 million had been paid and the remaining $0.2 million was recorded within accrued and other current liabilities in the consolidated balance sheets and is expected to be mostly paid in the remainder of 2025. Other than as set forth herein, the Company does not expect to incur any additional costs under the 2024 Plan. On March 31, 2025, the Board of Directors of the Company approved a reduction in force plan (the “2025 Plan”) as part of its broader efforts to prioritize investments in key strategic areas, including artificial intelligence, as well as to drive profitable growth in supporting its positive, long-term outlook and increasing stockholder value. On April 3, 2025, the Company commenced execution of the 2025 Plan, which resulted in the reduction of the Company’s global full-time employees by approximately 4%. During the three months ended September 30, 2025, the Company incurred a total of $0.1 million in restructuring costs under the 2025 Plan, consisting of notice period payments, which was recorded in sales and marketing expenses. During the nine months ended September 30, 2025, the Company incurred a total of $7.9 million in restructuring costs under the 2025 Plan, primarily consisting of notice period payments, severance payments, employee benefits and related costs, all of which are cash expenditures, of which $1.6 million was recorded in cost of revenue, $1.9 million was recorded in research and development expenses, $3.4 million was recorded in sales and marketing expenses, and $1.0 million was recorded in general and administrative expenses on the consolidated statements of operations and comprehensive income (loss). As of September 30, 2025, $7.7 million had been paid and the remaining $0.2 million was recorded within accrued and other current liabilities in the consolidated balance sheets and is expected to be mostly paid in the remainder of 2025. During the nine months ended September 30, 2025, the Company also incurred an additional $2.1 million in stock-based compensation costs related to the 2025 Plan due to additional vesting of share-based awards, of which $0.3 million was recorded in cost of revenue, $0.5 million was recorded in research and development expenses, $1.1 million was recorded in sales and marketing expenses, and $0.2 million was recorded in general and administrative expenses on the consolidated statements of operations and comprehensive income (loss). Other than as set forth herein, the Company does not expect to incur any additional costs under the 2025 Plan.